Human OX40/TNFRSF4 Antibody

Catalog #: MAB10563 Datasheet / COA / SDS

Recombinant Monoclonal Antibody

Catalog #	Availability	Size / Price	Qty
MAB10563-100
MAB10563-SP

Detection of OX40/TNFRSF4 in HEK293 Human Cell Line transfected with Human OX40/TNFRSF4 and eGFP by Flow Cytometry

2 Images

All OX40 Antibodies

Product Details

Supplemental Products

Reviews

Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human OX40/TNFRSF4 Antibody Summary

Species Reactivity

Human

Specificity

Detects human OX40/TNFRSF4 in direct ELISAs.

Source

Recombinant Monoclonal Rabbit IgG Clone # 2553D

Purification

Protein A or G purified from cell culture supernatant

Immunogen

Mouse myeloma cell line NS0-derived human OX40/TNFRSF4
Leu29-Ala216
Accession # P34389

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Endotoxin Level

<0.10 EU per 1 μg of the antibody by the LAL method.

Label

Unconjugated

Applications

Recommended Concentration

Sample

Flow Cytometry

0.25 µg/10⁶ cells

HEK293 Human Cell Line transfected with Human OX40/TNFRSF4 and eGFP

CyTOF-ready

Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

Neutralization

Measured by its ability to neutralize OX40L/TNFSF4-induced IL-8 secretion in the HT1080 human fibrosarcoma cell line transfected with human OX40/TNFRSF4. The Neutralization Dose (ND₅₀) is typically 25-250 ng/mL in the presence of 20 ng/mL Recombinant Human OX40L/TNFSF4.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Flow Cytometry

View Larger

Detection of OX40/TNFRSF4 in HEK293 Human Cell Line transfected with Human OX40/TNFRSF4 and eGFP by Flow Cytometry HEK293 human embryonic kidney cell line transfected with either (A) human OX40/TNFRSF4 or (B) irrelevant protein, and eGFP, was stained with Rabbit anti-human OX40/TNFRSF4 monoclonal antibody (Catalog # MAB10563) followed by Allophycocyanin-conjugated anti-Rabbit IgG Secondary Antibody (F0111). Quadrant markers were set based on control antibody staining (MAB1050, data not shown). Staining was performed using our Staining Membrane-Associated Proteins protocol.

Neutralization

View Larger

CXCL8/IL-8 Secretion Induced by OX40L/TNFSF4 and Neutralization by Human OX40/TNFRSF4 Antibody. Recombinant Human OX40L/TNFSF4 (1054-OX) stimulates CXCL8/IL-8 secretion in the HT1080 human fibrosarcoma cell line transfected with human OX40/TNFRSF4 in a dose-dependent manner (orange line), as measured by the Human CXCL8/IL-8 Quantikine ELISA Kit (D8000C). CXCL8/Il-8 Secretion elicited by Recombinant Human OX40L/TNFSF4 (20 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human OX40/TNFRSF4 Monoclonal Antibody (Catalog # MAB10563). The ND₅₀ is typically 25-250 ng/mL.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: OX40

OX40 (CD134; TNFRSF4) is a T cell co-stimulatory molecule of the TNF receptor superfamily that coordinates with other co-stimulators (CD28, CD40, CD30, CD27 and 4-1BB) to manage the activation of the immune response (1-3). Human OX40 is a 48 kDa type I transmembrane glycoprotein with a 28 amino acid (aa) signal sequence, a 185 aa extracellular domain (ECD) that contains a cysteine-rich region, a 20 aa transmembrane segment, and a 41 aa cytoplasmic domain (4). The ECD of human OX40 shares 63% sequence identity with the ECD of mouse and rat OX40. OX40 is up-regulated on CD4⁺ and CD8⁺ T cells upon engagement of the TCR by antigen presenting cells along with co-stimulation by CD40-CD40 Ligand and CD28-B7 (5, 6). OX40 Ligand is primarily expressed on antigen presenting cells (5). OX40 Ligand engagement of OX40 on activated CD4⁺ T cells results in increased T cell survival, proliferation, and cytokine production. It also inhibits the conversion of effector T cells into immunosuppressive regulatory T cells (Tregs) and can promote the maintenance of and recall response in memory T cells (3, 7-10). OX40 is constitutively expressed on Tregs and enhances the sensitivity of Tregs to IL-2, thus promoting Treg proliferation. OX40 has also been shown to decrease the cells’ immunosuppressive activity on effector T cells (11-14). OX40-OX40 Ligand signaling is involved in allergic airway inflammation, graft-versus-host disease and autoimmune disease (6, 15, 16). Mutations in OX40 and OX40 Ligand are associated with cardiovascular disease (17, 18).

References

Hori, T. (2006) Int. J. Hematol. 83:17.
Latza, U. et al. (1994) Eur. J. Immunol. 24:677.
Salek-Ardakani, S. et al. (2003) J. Exp. Med. 198:315.
al-Shamkhani, A. et al. (1996) Eur. J. Immunol. 26:1695.
Moran, A.E. et al. (2013) Curr. Opin. Immunol. 25:230.
Gramaglia, I. et al. (1998) J. Immunol. 161:6510.
Xiao, X. et al. (2008) J. Immunol. 181:3193.
So, T. and M. Croft (2007) J. Immunol. 179:1427.
Mousavi, S.F. et al. (2008) J. Immunol. 181:5990.
Bansal-Pakala, P. et al. (2001) Nat. Med. 7:907.
Piconese, S. et al. (2010) Eur. J. Immunol. 40:2902.
Griseri, T. et al. (2010) J. Exp. Med. 207:699.
Xiao, X. et al. (2012) J. Immunol. 188:892.
Vu, M.D. et al. (2007) Blood 110:2501.
Damayanti, T. et al. (2010) Am. J. Respir. Crit. Care Med. 181:688.
Xiao, X. et al. (2012) Nat. Immunol. 13:981.
Nakano, M. et al. (2010) Cardiovasc. Res. 88:539.
Ishii, N. et al. (2010) Adv. Immunol. 105:63.
Godfrey, W.R. et al. (1994) J. Exp. Med. 180:757

Entrez Gene IDs

7293 (Human); 22163 (Mouse); 25572 (Rat); 102145978 (Cynomolgus Monkey)

Alternate Names

ACT-135; ACT35 antigen; ACT35ATC35 antigen; CD134 antigen; CD134; Ly-70; OX40 cell surface antigen; OX40 homologue; OX40; OX40L receptor; OX40lymphoid activation antigene ACT35; TAX transcriptionally-activated glycoprotein 1 receptor; tax-transcriptionally activated glycoprotein 1 receptor; TNFRSF4; tumor necrosis factor receptor superfamily member 4; tumor necrosis factor receptor superfamily, member 4; Txgp1; TXGP1L; TXGP1LOX40 antigen